JP2019516737A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516737A5
JP2019516737A5 JP2018560884A JP2018560884A JP2019516737A5 JP 2019516737 A5 JP2019516737 A5 JP 2019516737A5 JP 2018560884 A JP2018560884 A JP 2018560884A JP 2018560884 A JP2018560884 A JP 2018560884A JP 2019516737 A5 JP2019516737 A5 JP 2019516737A5
Authority
JP
Japan
Prior art keywords
methyl
amino
benzenesulfonamide
thiazol
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018560884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019516737A (ja
JP6938545B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/033634 external-priority patent/WO2017201468A1/en
Publication of JP2019516737A publication Critical patent/JP2019516737A/ja
Publication of JP2019516737A5 publication Critical patent/JP2019516737A5/ja
Priority to JP2021142186A priority Critical patent/JP2021185189A/ja
Application granted granted Critical
Publication of JP6938545B2 publication Critical patent/JP6938545B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018560884A 2016-05-20 2017-05-19 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用 Active JP6938545B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021142186A JP2021185189A (ja) 2016-05-20 2021-09-01 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662339773P 2016-05-20 2016-05-20
US62/339,773 2016-05-20
US201662432152P 2016-12-09 2016-12-09
US62/432,152 2016-12-09
PCT/US2017/033634 WO2017201468A1 (en) 2016-05-20 2017-05-19 Benzenesulfonamide compounds and their use as therapeutic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021142186A Division JP2021185189A (ja) 2016-05-20 2021-09-01 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2019516737A JP2019516737A (ja) 2019-06-20
JP2019516737A5 true JP2019516737A5 (OSRAM) 2020-06-25
JP6938545B2 JP6938545B2 (ja) 2021-09-22

Family

ID=58794232

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018560884A Active JP6938545B2 (ja) 2016-05-20 2017-05-19 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
JP2021142186A Withdrawn JP2021185189A (ja) 2016-05-20 2021-09-01 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
JP2023099277A Withdrawn JP2023108032A (ja) 2016-05-20 2023-06-16 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
JP2025068729A Pending JP2025105687A (ja) 2016-05-20 2025-04-18 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021142186A Withdrawn JP2021185189A (ja) 2016-05-20 2021-09-01 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
JP2023099277A Withdrawn JP2023108032A (ja) 2016-05-20 2023-06-16 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
JP2025068729A Pending JP2025105687A (ja) 2016-05-20 2025-04-18 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用

Country Status (23)

Country Link
US (4) US10246453B2 (OSRAM)
EP (1) EP3458449B1 (OSRAM)
JP (4) JP6938545B2 (OSRAM)
KR (1) KR102366077B1 (OSRAM)
CN (1) CN109526219B (OSRAM)
AU (2) AU2017268006B2 (OSRAM)
CA (1) CA3023465C (OSRAM)
CL (1) CL2018003260A1 (OSRAM)
CO (1) CO2018012485A2 (OSRAM)
ES (1) ES3022639T3 (OSRAM)
HR (1) HRP20250505T1 (OSRAM)
HU (1) HUE071358T2 (OSRAM)
IL (1) IL262834B (OSRAM)
MX (1) MX386471B (OSRAM)
MY (1) MY199208A (OSRAM)
PH (1) PH12018502378B1 (OSRAM)
PL (1) PL3458449T3 (OSRAM)
RS (1) RS66796B1 (OSRAM)
RU (1) RU2769827C2 (OSRAM)
SG (2) SG10201912216VA (OSRAM)
TN (1) TN2018000385A1 (OSRAM)
WO (1) WO2017201468A1 (OSRAM)
ZA (1) ZA201807518B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109526219B (zh) 2016-05-20 2021-03-12 泽农医药公司 苯磺酰胺及其作为治疗剂的用途
SG10201912372XA (en) 2016-12-09 2020-02-27 Xenon Pharmaceuticals Inc Benzenesulfonamide compounds and their use as therapeutic agents
UA127024C2 (uk) 2018-06-13 2023-03-15 Ксенон Фармасьютікалз Інк. Бензолсульфонамідні сполуки та їх застосування як терапевтичних агентів
PE20211066A1 (es) 2018-08-31 2021-06-09 Xenon Pharmaceuticals Inc Compuestos de sulfonamida sustituidos con heteroarilo y su uso como agentes terapeuticos
WO2020047312A1 (en) * 2018-08-31 2020-03-05 Xenon Pharmaceuticals Inc. Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors
WO2021102314A1 (en) * 2019-11-21 2021-05-27 University Of Utah Research Foundation Trpv4 receptor ligands
WO2022077095A1 (en) * 2020-10-13 2022-04-21 Xenon Pharmaceuticals Inc. Use of the navi.6 sodium channel blocker (s)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-5-methyl-n( thiazol-4-yl)benzenesulfonamide, together with strong inducers of cytochrome p450 3a4, in the treatment of conditions associated with nav1.6 activity
US20230404913A1 (en) * 2020-10-13 2023-12-21 Xenon Pharmaceuticals, Inc. Pharmaceutical formulations for treating diseases associated with voltage-gated sodium channels
US20250333404A1 (en) * 2022-06-02 2025-10-30 Neurocrine Biosciences, Inc. Deuterated compounds
AR133184A1 (es) * 2023-07-07 2025-09-03 Novartis Ag Bloqueadores de canales de sodio
WO2025024795A1 (en) * 2023-07-27 2025-01-30 Neurocrine Biosciences, Inc. Crystalline forms
WO2025103409A1 (zh) * 2023-11-16 2025-05-22 南京同诺康医药科技有限公司 Nmt抑制剂及其制备方法和用途
WO2025132758A1 (en) 2023-12-21 2025-06-26 Syngenta Crop Protection Ag Pesticidally active quinazoline compounds

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5877193A (en) 1996-07-19 1999-03-02 Hoffmann-La Roche Inc. Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
JP2001524124A (ja) 1997-05-07 2001-11-27 ガレン(ケミカルズ)リミティド テストステロンおよびテストステロン前駆体の投与のための膣内薬物送達用具
WO2000042003A1 (en) 1999-01-13 2000-07-20 Warner-Lambert Company Benzenesulfonamide derivatives and their use as mek inhibitors
TR200200205T2 (tr) 1999-07-16 2002-06-21 Warner-Lambert Company MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US8933236B2 (en) * 2012-05-22 2015-01-13 Xenon Pharmaceuticals Inc. N-substituted benzamides and methods of use thereof
FR2836917B1 (fr) 2002-03-11 2006-02-24 Lipha Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
EP1531815B1 (en) 2002-06-27 2014-09-24 Novo Nordisk A/S Glucokinase activators
WO2004092123A2 (en) 2003-04-10 2004-10-28 Microbia, Inc. Inhibitors of fungal invasion
WO2005000309A2 (en) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Chemical compounds
JP2009513523A (ja) 2003-07-08 2009-04-02 ノバルティス アクチエンゲゼルシャフト ベンゼンスルホニルアミノ化合物およびそれらを含む医薬組成物
CA2539227A1 (en) 2003-08-08 2005-02-17 Vertex Pharmaceuticals Incorporated Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
HU227684B1 (en) 2003-08-29 2011-11-28 Sanofi Aventis Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
WO2006038594A1 (ja) * 2004-10-04 2006-04-13 Ono Pharmaceutical Co., Ltd. N型カルシウムチャネル阻害薬
EP1888544A2 (en) 2004-12-17 2008-02-20 Takeda San Diego, Inc. Hydroxysteroid dehydrogenase inhibitors
GB0510139D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
WO2007039171A1 (en) 2005-10-06 2007-04-12 Sanofi-Aventis 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
EP2308872A1 (en) * 2005-12-21 2011-04-13 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
WO2008019967A2 (en) * 2006-08-15 2008-02-21 F. Hoffmann-La Roche Ag Phenyl, pyridine and quinoline derivatives
ZA200902384B (en) 2006-10-19 2010-07-28 Signal Pharm Llc Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
ES2523196T3 (es) 2007-07-13 2014-11-21 Icagen, Inc. Inhibidores de los canales de sodio
CA2693588C (en) 2007-07-13 2015-11-17 Icagen, Inc. Sodium channel inhibitors
WO2009013171A2 (en) 2007-07-24 2009-01-29 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
WO2009157418A1 (ja) 2008-06-25 2009-12-30 第一三共株式会社 カルボン酸化合物
CN102099356A (zh) 2008-07-01 2011-06-15 沃泰克斯药物股份有限公司 用作离子通道调节剂的杂环衍生物
US20110294853A1 (en) 2008-09-12 2011-12-01 Benjamin Pelcman Bis Aromatic Compounds for Use in the Treatment of Inflammation
CN102348697B (zh) 2009-01-12 2014-12-10 辉瑞股份有限公司 磺酰胺衍生物
JP5830534B2 (ja) 2010-07-09 2015-12-09 ファイザー・リミテッドPfizer Limited 化合物
MX2013001970A (es) 2010-08-20 2013-08-09 Hutchison Medipharma Ltd Compuestos de pirrolopirimidina y usos de los mismos.
CA2844799A1 (en) 2011-08-17 2013-02-21 Amgen Inc. Heteroaryl sodium channel inhibitors
RU2014121489A (ru) 2011-10-28 2015-12-10 Мерк Шарп И Доум Корп. Соединения бензоксазолинона с селективной активностью в отношении потенциалзависимых натриевых каналов
JP6014154B2 (ja) * 2011-10-31 2016-10-25 ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
WO2013064984A1 (en) 2011-10-31 2013-05-10 Xenon Pharmaceuticals Inc. Biaryl ether sulfonamides and their use as therapeutic agents
US8889741B2 (en) * 2012-02-09 2014-11-18 Daiichi Sankyo Company, Limited Cycloalkane derivatives
WO2013122897A1 (en) 2012-02-13 2013-08-22 Amgen Inc. Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
RU2645711C2 (ru) 2012-10-15 2018-02-28 Дэвунг Фармасьютикал Ко., Лтд. Блокаторы натриевых каналов, способ их получения и их применение
JP2015535251A (ja) 2012-10-26 2015-12-10 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 電位作動型ナトリウムチャネルにおいて選択的活性を有するベンゾオキサゾリノン化合物
BR112015008987A2 (pt) 2012-10-26 2017-07-04 Merck Sharp & Dohme composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de uma composição farmacêutica
TW201443025A (zh) 2013-04-19 2014-11-16 Pfizer Ltd 化學化合物
TW201512171A (zh) 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物
WO2014201173A1 (en) 2013-06-12 2014-12-18 Amgen Inc. Bicyclic sulfonamide compounds as sodium channel inhibitors
GB201310542D0 (en) 2013-06-13 2013-07-31 Antabio Sas Compounds
WO2015035278A1 (en) 2013-09-09 2015-03-12 Bristol-Myers Squibb Company RORγ MODULATORS
KR20160054570A (ko) 2013-09-10 2016-05-16 크로모셀 코포레이션 통증과 당뇨병의 치료를 위한 나트륨 통로 조절인자
CR20160296A (es) 2013-11-27 2016-09-20 Genentech Inc Benzamidas sustituidas y métodos para usarlas
WO2015077905A1 (en) 2013-11-29 2015-06-04 Merck Sharp & Dohme Corp. Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
EP3087059B1 (en) 2013-12-23 2020-04-29 Purdue Pharma L.P. Indazoles and use thereof
WO2016007534A1 (en) * 2014-07-07 2016-01-14 Genentech, Inc. Therapeutic compounds and methods of use thereof
CN106795149B (zh) 2015-05-05 2019-09-24 上海海雁医药科技有限公司 双环取代的苯磺酰胺衍生物、其制法与医药上的用途
EP3389654B1 (en) 2015-12-18 2023-08-16 Merck Sharp & Dohme LLC Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
CN109526219B (zh) 2016-05-20 2021-03-12 泽农医药公司 苯磺酰胺及其作为治疗剂的用途
EP3541373B1 (en) 2016-11-17 2023-11-01 Merck Sharp & Dohme LLC Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
SG10201912372XA (en) 2016-12-09 2020-02-27 Xenon Pharmaceuticals Inc Benzenesulfonamide compounds and their use as therapeutic agents
UA127024C2 (uk) * 2018-06-13 2023-03-15 Ксенон Фармасьютікалз Інк. Бензолсульфонамідні сполуки та їх застосування як терапевтичних агентів
WO2020047312A1 (en) 2018-08-31 2020-03-05 Xenon Pharmaceuticals Inc. Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

Similar Documents

Publication Publication Date Title
JP2019516737A5 (OSRAM)
RU2018145045A (ru) Соединения бензолсульфонамида и их применение в качестве терапевтических средств
JP2010533158A5 (OSRAM)
JP5261383B2 (ja) ヒトプロテインチロシンホスファターゼ阻害剤および使用法
RU2005106844A (ru) [1,2,4]оксодиазолы (варианты), способ их получения, и фармацевтическая композиция и способ (варианты) ингибирования активации метаботропных глютаматных рецепторов-5
JP2006503009A5 (OSRAM)
JP2015517580A5 (OSRAM)
RU2009109147A (ru) Органические соединения
JP2004502670A5 (OSRAM)
JP2021500345A5 (OSRAM)
JP2018535999A5 (OSRAM)
JP2009542659A5 (OSRAM)
JP2020530446A5 (OSRAM)
JP2007528887A5 (OSRAM)
JP2020516671A5 (OSRAM)
JP2005504058A5 (OSRAM)
JP2006500348A5 (OSRAM)
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
JP2006506340A5 (OSRAM)
JP2009525340A5 (OSRAM)
JP2013533868A5 (OSRAM)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2006524686A5 (OSRAM)
JP2018507234A5 (OSRAM)
RU2019117556A (ru) Индазольные производные, пригодные в качестве ингибиторов диацилглицерид o-ацилтрансферазы 2